Egypt develops 153 fever hospitals during COVID; has sufficient stock of vaccines: Spox



Wed, 22 Jun 2022 - 12:39 GMT


Wed, 22 Jun 2022 - 12:39 GMT

Patient at hospital - FILE

Patient at hospital - FILE

CAIRO – 22 June 2022: Egypt will be able to provide a strategic stockpile of medicines, vaccines and serums at a cost of L.E. 2.1 billion, according to Spokesman for the Ministry of Health and Population Hossam Abdel Ghaffar.


He added that the country also has a strategic stock of children formula is also available.


The spokesman for the Ministry of Health and Population pointed out that about 153 fever hospitals were developed during the Corona virus pandemic at a cost of 438 million pounds.


As part of the development works in the health sector, Egypt announced establishing the first factory for blood plasma derivatives as per president’s instructions, to help achieve self-sufficiency in plasma derivates, thus providing medicines for many chronic diseases.


“The cost of the plasma derivatives project amounted to 423 million pounds,” said the spokesperson. He added that a serum complex was opened and operated in Helwan, in addition to establishing the National Serum and Vaccine Complex.


The Ministry of Health and Population revealed the details of the health infrastructure development projects, stressing that 1,139 hospitals were developed and upgraded at a value of 27 billion and 561 million pounds, indicating that they provide medical services consistent with quality standards.


A total of 51 hospitals, 310 units and centers have been established at a cost of 22 billion 133 million pounds within the comprehensive health insurance system in the governorates of the first phase.


He further added that an ambulance facility was developed through 84 projects at a cost of 4 billion and 159 million pounds, while the cost of projects for public health initiatives amounted to 5.99 billion pounds.



Leave a Comment

Be Social